"Elevated serum level of B‐cell activating factor (BAFF) after rituximab therapy in pemphigus vulgaris patients suggests a possible therapeutic efficacy of B‐cell depletion therapies combined with anti‐BAFF agents"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Elevated serum level of B‐cell activating factor (BAFF) after rituximab therapy in pemphigus vulgaris patients suggests a possible therapeutic efficacy of B‐cell depletion therapies combined with anti‐BAFF agents

Rituximab is widely used for treatment of pemphigus patients. B‐cell activating factor (BAFF) and a proliferation‐inducing ligand (APRIL) play key roles in B cell survival, maturation, and differentiation. Here, the… Click to show full abstract

Keywords: cell; baff; cell activating; factor baff; activating factor; rituximab

Journal Title: International Journal of Dermatology
Year Published: 2022

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended